Search Results for "triptans"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for triptans. Results 21 to 24 of 24 total matches.
See also: Maxalt
Ziprasidone (Geodon) For Schizophrenia
The Medical Letter on Drugs and Therapeutics • Jun 11, 2001 (Issue 1106)
dopamine and
serotonin receptor antagonist, ziprasidone is also a serotonin receptor agonist ...
Ziprasidone (Geodon - Pfizer), a benzisothiazolyl piperazine, has been approved by the FDA for oral treatment of schizophrenia. An intramuscular formulation will probably be available in the near future.
Liraglutide (Saxenda) for Weight Loss
The Medical Letter on Drugs and Therapeutics • Jun 22, 2015 (Issue 1471)
caps 120 mg tid 2.5-3.4 kg8 512.10
Alli9 (GSK) 60 mg caps 60 mg tid 44.00
Serotonin Receptor Agonist ...
The injectable glucagon-like peptide-1 (GLP-1)
receptor agonist liraglutide, previously approved by the
FDA for treatment of type 2 diabetes as Victoza, has
now also been approved at a higher dose as Saxenda
(Novo Nordisk) for chronic weight management
in adults with a BMI ≥30, or a BMI ≥27 with a
weight-related comorbidity such as hypertension,
dyslipidemia, or diabetes.
Atogepant (Qulipta) for Migraine Prevention
The Medical Letter on Drugs and Therapeutics • Nov 01, 2021 (Issue 1636)
-related migraine headaches can sometimes
be prevented with use of an NSAID or a triptan
(particularly ...
Atogepant (Qulipta – Abbvie), an oral small-molecule
calcitonin gene-related peptide (CGRP) receptor
antagonist ("gepant"), has been approved by the
FDA for prevention of episodic migraine in adults. It
is the second oral CGRP receptor antagonist to be
approved in the US for this indication; the first was
rimegepant (Nurtec ODT), which is also approved
for acute treatment of migraine. Parenteral CGRP
monoclonal antibodies are approved for prevention
of migraine (see Table 3).
Comparison Table: Drugs for Parkinson's Disease (online only)
The Medical Letter on Drugs and Therapeutics • Feb 22, 2021 (Issue 1618)
adverse effects
iSerotonin receptor agonists such as ondansetron
(Zofran, and others ...
View the Comparison Table: Drugs for Parkinson's Disease